GlobalFoundries Inc. Ordinary Shares vs IDEXX Laboratories, Inc. — how do they compare? GlobalFoundries Inc. Ordinary Shares trades at $47.66 (market cap $27.51B), while IDEXX Laboratories, Inc. trades at $518.98 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and GlobalFoundries Inc. Ordinary Shares pays a 0.97% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold GlobalFoundries Inc. Ordinary Shares for 0 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| GFS | IDXX | |
|---|---|---|
Market Cap | $27.51B | $40.43B |
Volume | 10,416,572 | 692,164 |
Sector | Technology | Health |
52-Week High | $89.96 | $766.68 |
52-Week Low | $32.24 | $504.70 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $26.80B | $41.32B |
Dividend Yield | 0.97% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GlobalFoundries is a semiconductor foundry that manufactures chips for other companies. Its technologies serve automotive, communications, industrial, and consumer markets.
Read more on GFS →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →